TP53 and breast cancer: Nevertheless, it should be noted that ZEB1 reactivation is a common feature of aggressive and undifferentiated human breast cancers, especially in the claudin-low intrinsic subtype (88), and that alterations of P53-pathways play a crucial role in human cancers (89).